GoPath Diagnostics

03/10/2026

Congratulations to the winners of the 2026 CAPA x GoPath Best Abstract Award! 🏆🎉

We are so proud to celebrate the outstanding research and dedication of this year's recipients, whose work spans cutting-edge topics in spatial transcriptomics, genomics, and digital pathology. 🔬🧬 Thank you to all who submitted abstracts and to CAPA for partnering with us on this incredible competition.

03/05/2026

Did you know colorectal cancer is one of the most preventable yet often overlooked cancers? Early detection can save lives, especially when combined with routine screening and awareness of hereditary risk factors. During Colorectal Cancer Awareness Month, we encourage conversations about symptoms, screening timelines, and the importance of understanding family history. Empowering patients and providers with knowledge is key to reducing the burden of this disease.

Learn more and get involved through the Colorectal Cancer Alliance: https://colorectalcancer.org/get-involved/advocate/colorectal-cancer-awareness-month

02/28/2026

Today, we recognize the strength and resilience of those living with rare diseases and the efforts driving better diagnosis, research, and care. Visit the Rare Disease Day website to learn more and see how awareness can create change. 💜

https://www.rarediseaseday.org/

02/26/2026

We’re counting down to USCAP 2026 in San Antonio! Learn how GoPath’s molecular and anatomic pathology expertise helps deliver smarter diagnostics and better patient outcomes.

📍 Find us at booth 456 — see what’s new in our test menu and genetics solutions.

02/25/2026

As National Cancer Prevention Month comes to a close, we’re reminded that prevention is powerful year-round. From healthy habits to regular screenings, every step makes a difference. Continue learning and take action with the American Association for Cancer Research (AACR): https://www.aacr.org/patients-caregivers/awareness-months/national-cancer-prevention-month/

02/19/2026

The GoPath team is heading to San Antonio for the 115th Annual USCAP Meeting next month! 🎯

Stop by booth 456 to see how our advanced pathology and molecular diagnostic solutions can elevate your practice.

🔬 Comprehensive Testing: Molecular, FISH, flow cytometry, histology, and cytology, all from one trusted partner.
🧬 GeneticsNow® Panels: Actionable NGS results for hereditary cancer risk assessment.
🩸 Subspecialty Pathology Expertise: GI, GU, Hematopathology, and Dermatopathology with integrated IHC and molecular insights.
💡 Biopharma Support: Contract research and central lab services customized for clinical trials and regulatory success.

Learn more at https://www.gopathdx.com/uscap-26

02/17/2026

Happy Lunar New Year 🐎✨

Wishing you prosperity, good health, and momentum as we welcome the Year of the Horse in 2026. May this new year bring steady progress, strong partnerships, and new growth opportunities.🌟

02/12/2026

How can communication help those living with hereditary cancer risk?

University of South Florida professor Dr. Marleah Dean Kruzel partners with the CDC to raise awareness through personal storytelling and research on genetic risk communication. Her work sheds light on the unique experiences of “previvors” and the importance of support after genetic testing.

Read more from the USF College of Arts and Sciences about how her mission is helping others navigate uncertainty and make informed health decisions:

University of South Florida

02/10/2026

Understanding breast self-awareness is an important part of early cancer detection. Experts say it’s about knowing how your breasts normally look and feel so you can notice changes early. Learn why doctors are encouraging self-awareness alongside regular mammograms to support prevention.

Read more from the AP:

Breast self-awareness is a more flexible approach to preventing breast cancer that goes along with other essential screening measures.

02/04/2026

💪 Prevention starts with action, and it can save lives. Nearly 40% of cancer cases are linked to preventable causes like smoking, excess weight, and physical inactivity.

This February, during National Cancer Prevention Month, let’s recommit to healthier habits that lower our risk of cancer. Small steps like staying active, eating well, and protecting your skin can make a big difference.

Learn more from the American Association for Cancer Research (AACR): https://www.aacr.org/patients-caregivers/awareness-months/national-cancer-prevention-month/

An estimated 40 percent of all cancers diagnosed and nearly half of all cancer deaths in the U.S. can be attributed to preventable causes.

01/30/2026

More people are living longer after cancer than ever before. 🌟

Today, 7 in 10 people diagnosed with cancer live at least 5 years after their diagnosis, a major leap from the 1970s. Thanks to advancements in research, treatment, and earlier detection, even late-stage cancers are experiencing improved survival rates. Every statistic represents more birthdays, more family moments, and more hope for the future.

Read more from the American Cancer Society:

Milestone in cancer survival: 7 in 10 people reach the 5-year mark

01/28/2026

What if a single germline variant could reshape how you think about prostate cancer hormone therapy?

A new GoPath study examines the HSD3B1 (1245C) adrenal‑permissive allele in 631 patients, where nearly 40% carried at least one copy and over 7% were homozygous. It outlines how genotype insights can inform expectations for androgen deprivation therapy and long‑term hormonal strategies. Read the full article to explore how incorporating germline testing may support more individualized prostate cancer management.

Read more: https://www.gopathdx.com/blog/tpost/f459a6g9r1-prevalence-of-the-hsd3b1-1245c-variant-a